LivaNova PLC (NASDAQ:LIVN – Get Rating) shares were up 3.5% during trading on Friday . The stock traded as high as $50.05 and last traded at $50.05. Approximately 1,406 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 371,263 shares. The stock had previously closed at $48.37.
Wall Street Analysts Forecast Growth
Several analysts have commented on LIVN shares. Needham & Company LLC lowered their price target on LivaNova from $106.00 to $88.00 and set a "buy" rating for the company in a report on Thursday, August 4th. StockNews.com upgraded LivaNova from a "hold" rating to a "buy" rating in a report on Friday, September 9th. Finally, The Goldman Sachs Group decreased their target price on LivaNova from $85.00 to $73.00 and set a "buy" rating for the company in a report on Tuesday, August 16th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, LivaNova has a consensus rating of "Buy" and a consensus target price of $90.20.
Get LivaNova alerts:LivaNova Stock Up 5.0 %
The stock has a fifty day moving average price of $58.69 and a 200-day moving average price of $66.24. The firm has a market cap of $2.71 billion, a PE ratio of -90.66 and a beta of 0.91. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.47 and a current ratio of 2.93.
LivaNova (NASDAQ:LIVN – Get Rating) last released its quarterly earnings results on Wednesday, August 3rd. The company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.51 by $0.02. The firm had revenue of $254.20 million for the quarter, compared to analyst estimates of $249.55 million. LivaNova had a positive return on equity of 9.35% and a negative net margin of 2.74%. LivaNova's revenue for the quarter was down 3.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.52 EPS. Research analysts expect that LivaNova PLC will post 1.91 EPS for the current year.Hedge Funds Weigh In On LivaNova
Several hedge funds and other institutional investors have recently bought and sold shares of LIVN. Sumitomo Mitsui Trust Holdings Inc. acquired a new position in LivaNova during the 1st quarter worth approximately $64,579,000. Loomis Sayles & Co. L P raised its position in shares of LivaNova by 601.5% in the 2nd quarter. Loomis Sayles & Co. L P now owns 601,679 shares of the company's stock valued at $37,587,000 after purchasing an additional 515,914 shares in the last quarter. Goldman Sachs Group Inc. raised its position in shares of LivaNova by 63.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 993,066 shares of the company's stock valued at $81,263,000 after purchasing an additional 383,973 shares in the last quarter. Marshall Wace LLP raised its position in shares of LivaNova by 397.7% in the 4th quarter. Marshall Wace LLP now owns 461,729 shares of the company's stock valued at $40,370,000 after purchasing an additional 368,955 shares in the last quarter. Finally, Teacher Retirement System of Texas raised its position in shares of LivaNova by 121.4% in the 2nd quarter. Teacher Retirement System of Texas now owns 307,501 shares of the company's stock valued at $19,210,000 after purchasing an additional 168,616 shares in the last quarter. 98.89% of the stock is owned by institutional investors and hedge funds.
About LivaNova
(Get Rating)
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.
Featured Articles
- Get a free copy of the StockNews.com research report on LivaNova (LIVN)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Thor Industries Hammers Out A Bottom
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.